![Tassos Konstantinou](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Tassos Konstantinou
Director/Board Member at Oxford Biotrans Ltd.
Profile
Tassos Konstantinou is currently a Non-Executive Director at Oxford Biotrans Ltd.
and a Director at Kynos Therapeutics Ltd.
He previously held positions as a Director at Oxular Ltd.
and STORM Therapeutics Ltd.
Konstantinou holds a doctorate from the University of Oxford and a graduate degree from The University of Chicago.
Tassos Konstantinou active positions
Companies | Position | Start |
---|---|---|
Oxford Biotrans Ltd.
![]() Oxford Biotrans Ltd. Chemicals: Major DiversifiedProcess Industries Oxford Biotrans Ltd. develops and commercializes enzymatic process technologies that produce chemical compounds. The firm produces chemicals using ‘green’ biotransformation technology to starting materials into initial focus is on flavors and fragrances using its proprietary understanding of P450 enzyme catalyst technology. The company was founded by Luet Lok Wong in 2013 and is headquartered in Milton Park, the United Kingdom. | Director/Board Member | - |
Kynos Therapeutics Ltd.
![]() Kynos Therapeutics Ltd. BiotechnologyHealth Technology Kynos Therapeutics Ltd. develops medicines for therapies. The company is based in Edinburgh, UK. The British company was founded by Damian Mole, Scott Webster. The CEO is Jonathan R. Savidge. | Director/Board Member | - |
Former positions of Tassos Konstantinou
Companies | Position | End |
---|---|---|
STORM Therapeutics Ltd.
![]() STORM Therapeutics Ltd. BiotechnologyHealth Technology Storm Therapeutics Ltd. develops small molecule drugs that target RNA-modifying enzymes. It offers research and development of drug molecules for the treatment of specific cancers. The company was founded by Anthony Kouzarides and Eric Miska on April 21, 2015 and is headquartered in Cambridge, the United Kingdom. | Director/Board Member | - |
Oxular Ltd.
![]() Oxular Ltd. BiotechnologyHealth Technology Oxular Ltd. engages in research and experimental development on biotechnology. The firm develops retinal treatments to access specific small spaces in the eye and to provide drug distribution to tissues involved in retinal diseases. The company was founded by Tom Cavanagh and Ronald K. Yamamoto in 2014 and is headquartered in Oxford, the United Kingdom. | Director/Board Member | - |
Training of Tassos Konstantinou
University of Oxford | Doctorate Degree |
The University of Chicago | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 4 |
---|---|
Oxford Biotrans Ltd.
![]() Oxford Biotrans Ltd. Chemicals: Major DiversifiedProcess Industries Oxford Biotrans Ltd. develops and commercializes enzymatic process technologies that produce chemical compounds. The firm produces chemicals using ‘green’ biotransformation technology to starting materials into initial focus is on flavors and fragrances using its proprietary understanding of P450 enzyme catalyst technology. The company was founded by Luet Lok Wong in 2013 and is headquartered in Milton Park, the United Kingdom. | Process Industries |
Oxular Ltd.
![]() Oxular Ltd. BiotechnologyHealth Technology Oxular Ltd. engages in research and experimental development on biotechnology. The firm develops retinal treatments to access specific small spaces in the eye and to provide drug distribution to tissues involved in retinal diseases. The company was founded by Tom Cavanagh and Ronald K. Yamamoto in 2014 and is headquartered in Oxford, the United Kingdom. | Health Technology |
STORM Therapeutics Ltd.
![]() STORM Therapeutics Ltd. BiotechnologyHealth Technology Storm Therapeutics Ltd. develops small molecule drugs that target RNA-modifying enzymes. It offers research and development of drug molecules for the treatment of specific cancers. The company was founded by Anthony Kouzarides and Eric Miska on April 21, 2015 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Kynos Therapeutics Ltd.
![]() Kynos Therapeutics Ltd. BiotechnologyHealth Technology Kynos Therapeutics Ltd. develops medicines for therapies. The company is based in Edinburgh, UK. The British company was founded by Damian Mole, Scott Webster. The CEO is Jonathan R. Savidge. | Health Technology |
- Stock Market
- Insiders
- Tassos Konstantinou